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Abstract
Background: Cutaneous metastases in the facial region occur in less than 0.5% of patients with
metastatic cancer.
Case presentation: A 52-year-old woman who admitted with a lung and a skull skin nodule is
presented. She had a known diagnosis of uterine leiomyosarcoma following an extended total
hysterectomy two years ago. Excision biopsy of both nodules revealed metastatic disease.
Conclusion:  The appearance of a cutaneous nodule in a patient with a history of uterine
leiomyosarcoma might indicate a metastatic tumor lesion. Biopsy and immunohistochemistry are
essential for correct diagnosis.
Background
Leiomyosarcoma is a rare malignant neoplasm composed
of cells demonstrating smooth muscle differentiation.
Uterine leiomysarcoma accounts for 25–36% of uterine
sarcoma and 1% of all malignancies and has a poor prog-
nosis due to a high metastatic recurrence rate. They most
commonly arise de novo; however, a minority (5%) may
be associated with prior irradiation. The peak incidence
occurs in the 30–40 age range and reaches a plateau in the
middle age. Uterine leiomyosarcoma usually presents
with features of vaginal bleeding (77–95%), pelvic pain
(33%), uterine enlargement or a palpable pelvic mass
(20–50%) [1].
The commonly reported sites of metastasis from leio-
mysarcoma are the lung, kidney and liver [2]. Spread to
the thyroid, brain, bone, skeletal muscle, heart, parotid
gland and the oral cavity have also been reported [3-8].
Uterine leiomyosarcoma should be distinguished from
benign uterine metastasizing leiomyoma which is diag-
nosed several years after myomectomy or hysterectomy
with most commonly radiographic appearance of slow-
growing solitary or multiple lung nodules.
In this report we describe an unusual case of uterine leio-
myosarcoma metastasizing to the skull skin.
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Case presentation
A 52-year-old multiparous woman was referred to our
hospital in 2006 for post-menopausal abnormal uterine
bleeding. She underwent an extended total hysterectomy,
bilateral salpingho-oopherectomy and pelvic lym-
phadenectomy. Tumor cells infiltrated to the uterine
serosa and invasion of the tumor cells to the lymphatic
vessels was also noted. Immunohistochemistry demon-
strated that the tumor cells were positive for a-smooth
muscle actin. The patient was diagnosed with uterine lei-
omyosarcoma (intermediate grade) with positive pelvic
lymph nodes. Postoperatively she received further treat-
ment with combination chemotherapy composed of epi-
rubicin, cyclophosphamide and carboplatin for 6
months. She also received radiation therapy with a total of
45 Gy to the pelvis.
The patient remained asymptomatic for 2 years postoper-
atively. During regular follow up, computed tomography
demonstrated a suspicious lung lesion. Clinical examina-
tion also revealed a nodule measuring 4 × 4 cm on the
skull skin of the left temporal lobe (Figures 1, 2). There-
fore under general anesthesia, she underwent video-
assisted thoracic surgery for the pulmonary nodule
(wedge resection) and excision biopsy of the cutaneous
lesion at the same time. Both of them were diagnosed as
metastases from uterine leiomyosarcoma. The excised
skin nodule revealed a proliferation of atypical spindle
cells with a woven, palisading and rosette-forming pattern
surrounded by fibrocollagenous tissue, with a high
mitotic ratio (Figures 3, 4). Further immunohistochemi-
cal staining was positive for desmin and vimentin and this
confirmed the diagnosis. The patient was referred for
chemotherapy and 8 months later is still alive but with
multiple lung metastases.
Discussion
Smooth muscle is a component of many tissues and
organs. As a result, leiomyosarcoma can arise at almost
any anatomic site in the human body. In women, approx-
imately one third of leiomyosarcomas originate in the
gastrointestinal tract, particularly the small bowel and
colon and another one third are found in the uterus.
Clinical examination revealed a nodule on the skull skin Figure 1
Clinical examination revealed a nodule on the skull 
skin.
Macroscopic appearance of the resected nodule Figure 2
Macroscopic appearance of the resected nodule.
Pathology of the excised cutaneous nodule consistent with  metastatic uterine leiomyosarcoma (cellular eosinophilic  spindle cell tumor with nuclear atypia and mitosis) (HE ×40  and ×200) Figure 3
Pathology of the excised cutaneous nodule consistent 
with metastatic uterine leiomyosarcoma (cellular 
eosinophilic spindle cell tumor with nuclear atypia 
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Stage, age, tumor size and delivery status of the patient
were found to be the most important prognostic factors as
regards survival. Interestingly, it seems that higher parity
(up to three deliveries) had a negative influence on sur-
vival in cases of uterine sarcoma. The relationship
between parity and survival in cases of uterine sarcoma
should be evaluated more closely in larger series in the
future [9].
Extrafascial hysterectomy with pelvic lymph node sam-
pling with or without salpingo-oophorectomy is the sur-
gical gold standard. Debate concerning removal of adnexa
and the value of lymph node dissection (LND) is still
ongoing [10]. The survival of younger patients with leio-
myosarcoma without oophorectomy has been better in
one study which is very controversial. The rate of lymph
node metastasis has been between 0–47%, and in some
studies survival has not been significantly affected as
regards LND [11]. The role of adjuvant therapies is contro-
versial. Radiotherapy (RT) seems to improve local control
but not survival. Adjuvant chemotherapy (CT) does not
decrease the risk of metastatic spread or improve survival.
In recurrent uterine sarcomas the response rates in differ-
ent chemotherapeutic regimens have been between 0–
57%. However, the conclusion after a review of the litera-
ture was that it is reasonable to offer palliative CT to
patients with advanced uterine sarcoma. The effects of
hormone therapy in cases of recurrent uterine sarcoma
have been assessed in only a few studies [12].
A case of uterine leiomyosarcoma with synchronous lung
and cutaneous skull metastasis is presented.
Lung and breast cancers are the commonest epithelial
malignancies metastasizing to the skin in men and
women respectively. Clinically, cutaneous metastases
manifest as nodules, ulceration, cellulitis like lesions, bul-
lae or fibrotic processes [7].
Cutaneous metastases as a first sign of internal malig-
nancy occur infrequently. More commonly, they are early
indicators of metastatic disease [8]. Diagnosis may delay
several months, unless the skin lesion grows rapidly or
other sites such as the lung or liver affected by tumor
spread. In our case, the cutaneous metastasis was diag-
nosed simultaneously with the lung lesion.
Uterine leiomyosarcoma has a strong metastatic potential
to distant sites, because of its aggressiveness and propen-
sity for hematogenous spread. Cutaneous metastasis
although rare indicates tumor relapse. Early detection
requires high index of suspicion. Therefore, close inspec-
tion of new skin lesions in patients with history of malig-
nancy is imperative and diagnostic biopsy is essential.
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